Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
Antacids Market Size And Revenue Outlook Through 2030
The antacids market size has observed steady growth in recent years. It is anticipated to expand from $9.94 billion in 2025 to $10.18 billion in 2026, registering a compound annual growth rate (CAGR) of 2.5%. The historical increase in this market can be attributed to the rising prevalence of acid reflux and heartburn, greater awareness of digestive health, the expansion of retail pharmacy networks, the introduction of proton pump inhibitors, and the development of liquid and chewable formulations.
The antacids market is anticipated to experience consistent expansion in the coming years, projected to reach $11.57 billion in 2030 with a compound annual growth rate (CAGR) of 3.3%. This anticipated growth during the forecast period is driven by factors such as the increasing adoption of personalized medicine, a rising demand for natural and herbal antacids, the expansion of e-pharmacy and online sales channels, technological advancements in drug delivery, and market penetration in emerging regions. Significant trends expected during this period include a greater availability of over-the-counter products, the development of more combination antacid formulations, an increasing focus on pediatric and geriatric care, the proliferation of home healthcare solutions, and a pronounced shift towards natural and herbal antacids.
Get A Free Sample Report With In-Depth Market Insights:
Antacids Market Growth Factors Behind Sustained Expansion
The rising occurrence of inflammatory bowel disease (IBD) is projected to boost the expansion of the antacids market. IBD encompasses conditions marked by ongoing inflammation within the digestive system. Antacids are medicines developed to control stomach acid and are frequently used to treat heartburn and indigestion. For example, the International Foundation for Gastrointestinal Disorders (IFFGD) estimated that 5–10% of the worldwide population would experience IBS in 2023, with 25 and 45 million individuals in the United States suffering from it. Furthermore, a survey by the American Gastroenterological Association covering 33 countries on 6 continents, examining the prevalence of functional gastrointestinal disorders, found that over 40% of the 73,076 adult participants globally suffer from functional gastrointestinal disorders (FGID), which impact their quality of life and healthcare utilization. Consequently, the expanding incidence of inflammatory bowel disease is set to propel the growth of the antacids market in the future.
Antacids Market Segment Analysis Spotlighting Growth Areas
The antacids market covered in this report is segmented –
1) By Drug Class: Proton Pump Inhibitors, H2 Antagonist, Acid Neutralizers, Pro-Motility Agents
2) By Formulation Type: Tablet, Liquid, Powder, Other Formulation Types
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Other Distribution Channels
Subsegments:
1) By Proton Pump Inhibitors (PPIs): Omeprazole, Esomeprazole, Lansoprazole, Pantoprazole, Rabeprazole
2) By H2 Antagonists: Ranitidine, Famotidine, Cimetidine, Nizatidine
3) By Acid Neutralizers: Antacids, Sodium Bicarbonate
4) By Pro-Motility Agents: Metoclopramide, Domperidone
Antacids Market Industry Trends Fueling Future Revenue Growth
Major companies operating in the antacids market are introducing new products, including a variety of antacid flavors, to boost their profitability. Antacid flavors refer to the diverse taste options available for antacid products. For instance, in March 2023, Wonderbelly, a US-based digestive medicine company, launched three antacid flavors: Fruity Cereal (an exclusive to Target stores), Strawberry Milkshake, and Watermelon Mint. While Wonderbelly Antacid contains calcium carbonate, the same active ingredient as other brands, it differentiates itself by being a non-GMO and vegan product, free from talc, dyes, gluten, dairy, common allergens, synthetic sweeteners, artificial flavors, parabens, and preservatives. These products were developed in collaboration with gastroenterologists and pharmaceutical manufacturers to ensure their quality.
Major companies within the antacids market are innovating new products, such as anti-reflux antacids, to meet the rising consumer demand for effective heartburn and acid reflux solutions. Anti-reflux antacids are medications specifically designed to alleviate symptoms of gastroesophageal reflux disease (GERD) and related conditions through stomach acid neutralization. For example, in June 2024, Akums Drugs and Pharmaceuticals, an India-based pharmaceutical preparation manufacturing company, introduced a new chewable tablet for heartburn relief, which combines sodium alginate and potassium bicarbonate. Approved by the Drugs Controller General of India (DCGI), this dual-action formulation aims to provide effective relief from gastroesophageal reflux disease (GERD) symptoms. Sodium alginate forms a protective gel barrier to prevent acid reflux, while potassium bicarbonate neutralizes stomach acid for immediate relief.
Antacids Market Leading Companies: Who Holds The Strongest Market Presence?
Major companies operating in the antacids market are Walmart Equate LLC, Private Label, Pfizer Inc, Bayer AG, Sanofi S.A., Abbott Laboratories, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Boehringer Ingelheim GmbH, Reckitt Benckiser Group plc, WellSpring Pharmaceutical Corporation, Xiuzheng Pharmaceutical Group Company Limited, Bausch Health Companies Inc., Sun Pharmaceuticals Industries Ltd., Dr. Reddy’s Laboratories Ltd., Hikma Pharmaceuticals plc, Alkem Laboratories Ltd., Conba Group Co. Ltd., Chattem Chemicals Inc., China Resources Sanjiu Medical & Pharmaceutical Co. Ltd., Thornton and Ross Ltd., McNeil Consumer Pharmaceuticals Co., Advance Pharmaceutical Inc.
View The Full Antacids Market Report:
Antacids Market Geographic Spread And Regional Opportunities
North America was the largest region in the antacids market in 2025. The Middle East is expected to be the fastest-growing region in the global antacids market share. The regions covered in the antacids market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
